2023
DOI: 10.1038/s41467-023-38311-0
|View full text |Cite
|
Sign up to set email alerts
|

Genomic mutation landscape of skin cancers from DNA repair-deficient xeroderma pigmentosum patients

Abstract: Xeroderma pigmentosum (XP) is a genetic disorder caused by mutations in genes of the Nucleotide Excision Repair (NER) pathway (groups A-G) or in Translesion Synthesis DNA polymerase η (V). XP is associated with an increased skin cancer risk, reaching, for some groups, several thousand-fold compared to the general population. Here, we analyze 38 skin cancer genomes from five XP groups. We find that the activity of NER determines heterogeneity of the mutation rates across skin cancer genomes and that transcripti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(37 citation statements)
references
References 80 publications
3
8
0
Order By: Relevance
“…This includes the activities of OGG1-initiated BER, MutY-initiated BER, mismatch repair, nucleotide excision repair (NER), and accurate TLS bypass by DNA polymerase η. We therefore compared spontaneous and KBrO 3 -induced mutation spectra among WT human cell lines and those lacking OGG1 17 , MUTYH 17 , Pol η 47 , or HMCES, a recently identified replication-associated factor that participates in bypass of ssDNA lesions 4852 and protects cells from cytotoxicity associated with KBrO 3 exposure 48,51 . Loss of OGG1, MUTYH, and HMCES resulted in moderate ∼2 to 3-fold increases in the amount of spontaneously acquired mutations per genome compared to corresponding WT lines, while Pol η-deficiency failed to increase spontaneous mutagenesis (Supplemental Figure 11A).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…This includes the activities of OGG1-initiated BER, MutY-initiated BER, mismatch repair, nucleotide excision repair (NER), and accurate TLS bypass by DNA polymerase η. We therefore compared spontaneous and KBrO 3 -induced mutation spectra among WT human cell lines and those lacking OGG1 17 , MUTYH 17 , Pol η 47 , or HMCES, a recently identified replication-associated factor that participates in bypass of ssDNA lesions 4852 and protects cells from cytotoxicity associated with KBrO 3 exposure 48,51 . Loss of OGG1, MUTYH, and HMCES resulted in moderate ∼2 to 3-fold increases in the amount of spontaneously acquired mutations per genome compared to corresponding WT lines, while Pol η-deficiency failed to increase spontaneous mutagenesis (Supplemental Figure 11A).…”
Section: Resultsmentioning
confidence: 99%
“…hTERT-RPE-1 POLH -/-VCF files were available from 47 (Addgene Cat No. 48139) that contain guide RNAs that target the intron-exon junction of the second exon of HMCES (5'-TTGCGCCTACCAGGATCGGC and 5'-ACTTTAGACGGTGGTCACGG).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…This conclusion is further supported by analysis of the association of mutation rate and replication timing in xeroderma pigmentosum patients. Patients with severe impairment of the NER lost the association 11 . Interestingly, a recent analysis of the association of replication timing with mutation signatures across 5120 whole-genome sequenced tumors from 40 cancer types did not support this conclusion.…”
Section: Introductionmentioning
confidence: 99%
“…The progressive co-development of NGS technologies and cancer genomics databases have enabled the identification of distinct mutational signatures in various cancers, and so far about a half of the identified mutational signatures have underlying processes been assigned to them (1-4). Mutational signatures originate from the effects and interactions of a vast range of environmental and intrinsic sources, such as exposure to chemicals or physical factors like ultraviolet radiation among others, endogenously generated reactive oxygen species (ROS), errors in DNA replication, or defects in specific DNA repair mechanisms (5,6). Elucidating the specific vulnerabilities of cancer cells to different drugs and therapies can facilitate the development of more effective and personalized cancer treatments (7)(8)(9)(10).…”
Section: Introductionmentioning
confidence: 99%